Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) EBT Margin (2016 - 2025)

Historic EBT Margin for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2025 value amounting to 31086.25%.

  • Abeona Therapeutics' EBT Margin changed N/A to 31086.25% in Q2 2025 from the same period last year, while for Sep 2025 it was 16377.0%, marking a year-over-year change of. This contributed to the annual value of 1358.66% for FY2023, which is 22941700.0% up from last year.
  • Latest data reveals that Abeona Therapeutics reported EBT Margin of 31086.25% as of Q2 2025.
  • Abeona Therapeutics' 5-year EBT Margin high stood at 97227.08% for Q4 2021, and its period low was 19285.29% during Q4 2022.
  • Over the past 4 years, Abeona Therapeutics' median EBT Margin value was 1013.8% (recorded in 2021), while the average stood at 11815.23%.
  • As far as peak fluctuations go, Abeona Therapeutics' EBT Margin skyrocketed by 977546800bps in 2021, and later crashed by -1165123800bps in 2022.
  • Abeona Therapeutics' EBT Margin (Quarter) stood at 97227.08% in 2021, then crashed by -120bps to 19285.29% in 2022, then surged by 98bps to 304.49% in 2023, then surged by 10309bps to 31086.25% in 2025.
  • Its EBT Margin was 31086.25% in Q2 2025, compared to 304.49% in Q2 2023 and 19285.29% in Q4 2022.